ATE548658T1 - Peptidmarker zur diagnose von präeklampsie - Google Patents
Peptidmarker zur diagnose von präeklampsieInfo
- Publication number
- ATE548658T1 ATE548658T1 AT08705059T AT08705059T ATE548658T1 AT E548658 T1 ATE548658 T1 AT E548658T1 AT 08705059 T AT08705059 T AT 08705059T AT 08705059 T AT08705059 T AT 08705059T AT E548658 T1 ATE548658 T1 AT E548658T1
- Authority
- AT
- Austria
- Prior art keywords
- preeclampsia
- diagnosis
- peptide markers
- calcyclin
- marker
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2007/050014 WO2008085024A1 (en) | 2007-01-12 | 2007-01-12 | Identification and detection of peptides relating to specific disorders |
| PCT/NL2008/000021 WO2008085036A1 (en) | 2007-01-12 | 2008-01-14 | Peptide markers for diagnosis of preeclampsia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE548658T1 true ATE548658T1 (de) | 2012-03-15 |
Family
ID=38171286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08705059T ATE548658T1 (de) | 2007-01-12 | 2008-01-14 | Peptidmarker zur diagnose von präeklampsie |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20100240088A1 (de) |
| EP (2) | EP2118664B1 (de) |
| AT (1) | ATE548658T1 (de) |
| AU (2) | AU2008203968A1 (de) |
| CA (2) | CA2674737A1 (de) |
| NZ (1) | NZ578262A (de) |
| WO (4) | WO2008085024A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1937815B1 (de) | 2005-09-13 | 2015-05-13 | National Research Council of Canada | Verfahren und zusammensetzungen zur modulation der tumorzellaktivität |
| EP3358354B1 (de) | 2008-01-18 | 2020-07-15 | President and Fellows of Harvard College | Verfahren zur detektion von anzeichen einer krankheit oder eines leidens in körperflüssigkeiten |
| WO2009158423A1 (en) * | 2008-06-25 | 2009-12-30 | University Of Utah Research Foundation | Identifying and quantifying biomarkers associated with preeclampsia |
| IT1392551B1 (it) * | 2008-11-25 | 2012-03-09 | Bioindustry Park Del Canavese S P A | Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica |
| WO2011063523A1 (en) | 2009-11-24 | 2011-06-03 | Alethia Biotherapeutics Inc. | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| US9595099B2 (en) * | 2010-02-26 | 2017-03-14 | Carolyn M Salafia | Automated placental measurement |
| SG10201505724SA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
| MX382244B (es) | 2010-07-23 | 2025-03-13 | Harvard College | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales |
| US20130203624A1 (en) | 2010-07-23 | 2013-08-08 | President And Fellows Of Harvard College | Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions |
| CA2806293A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| KR101449100B1 (ko) | 2011-04-21 | 2014-10-13 | 가톨릭대학교 산학협력단 | 신경세포 데브리스 제거용 오스테오폰틴 |
| US20150004632A1 (en) | 2011-10-14 | 2015-01-01 | Aarhus Universitet | Diagnostic and prognostic use of prombp-complexes |
| WO2013123588A1 (en) | 2012-02-22 | 2013-08-29 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| EP2836832A4 (de) * | 2012-04-13 | 2015-10-14 | Univ Wayne State | Frühes trimester-screening für früh und spät manifestierte präeklampsie |
| CN104603289A (zh) | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
| SG11201408383SA (en) | 2012-06-15 | 2015-01-29 | Harry Stylli | Methods of detecting diseases or conditions using circulating diseased cells |
| SG11201408652SA (en) | 2012-06-26 | 2015-01-29 | Biodesix Inc | Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies |
| EP4202441A3 (de) | 2013-03-09 | 2023-07-26 | Immunis.AI, Inc. | Genexpressionsprofil in makrophagen zur diagnose von krebs |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| US10626464B2 (en) | 2014-09-11 | 2020-04-21 | Cell Mdx, Llc | Methods of detecting prostate cancer |
| ES2955883T3 (es) | 2015-06-19 | 2023-12-07 | Sera Prognostics Inc | Pares de biomarcadores para la predicción del parto prematuro |
| FR3038984B1 (fr) * | 2015-07-15 | 2020-01-10 | Universite de Bordeaux | Analyse proteomique de compartiments subcellulaires |
| WO2018151938A2 (en) * | 2017-02-17 | 2018-08-23 | The Methodist Hospital | Compositions and methods of determining a level of infection in a subject |
| AU2018317902B2 (en) | 2017-08-18 | 2025-02-20 | Sera Prognostics, Inc. | Pregnancy clock proteins for predicting due date and time to birth |
| AU2018324195B2 (en) | 2017-09-01 | 2024-12-12 | Venn Biosciences Corporation | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring |
| JPWO2019202767A1 (ja) * | 2018-04-17 | 2021-05-13 | 国立大学法人大阪大学 | 抗線維化剤及び線維症のバイオマーカー |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185243A (en) * | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
| US5436132A (en) * | 1993-02-13 | 1995-07-25 | Amano Pharmaceutical Co., Ltd. | Quantitative determination of tenascin as glioma marker |
| ITMI20011833A1 (it) * | 2001-08-31 | 2003-03-03 | San Raffaele Centro Fond | Agenti che regolano la permeabilita' vascolare |
| CA2519129A1 (en) * | 2003-03-18 | 2004-09-30 | Biovision Ag | Method for detecting alzheimer's disease and corresponding peptides and detection reagents |
| CA2565405A1 (en) * | 2004-06-18 | 2005-12-29 | F. Hoffmann-La Roche Ag | Use of protein cbp2 as a marker for colorectal cancer |
| EP1998789A4 (de) * | 2006-02-28 | 2009-04-22 | Metabolon Inc | Biomarker für amyotrophe lateralsklerose und verwendungsverfahren dafür |
-
2007
- 2007-01-12 WO PCT/NL2007/050014 patent/WO2008085024A1/en not_active Ceased
-
2008
- 2008-01-14 US US12/522,880 patent/US20100240088A1/en not_active Abandoned
- 2008-01-14 NZ NZ578262A patent/NZ578262A/en not_active IP Right Cessation
- 2008-01-14 EP EP08705059A patent/EP2118664B1/de not_active Not-in-force
- 2008-01-14 US US12/522,875 patent/US20100291612A1/en not_active Abandoned
- 2008-01-14 AT AT08705059T patent/ATE548658T1/de active
- 2008-01-14 AU AU2008203968A patent/AU2008203968A1/en not_active Abandoned
- 2008-01-14 AU AU2008203970A patent/AU2008203970A1/en not_active Abandoned
- 2008-01-14 WO PCT/NL2008/000020 patent/WO2008085035A1/en not_active Ceased
- 2008-01-14 WO PCT/NL2008/000021 patent/WO2008085036A1/en not_active Ceased
- 2008-01-14 CA CA002674737A patent/CA2674737A1/en not_active Abandoned
- 2008-01-14 WO PCT/NL2008/000019 patent/WO2008085034A1/en not_active Ceased
- 2008-01-14 EP EP08705057A patent/EP2118662A1/de not_active Withdrawn
- 2008-01-14 CA CA002674736A patent/CA2674736A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2674737A1 (en) | 2008-07-17 |
| WO2008085034A1 (en) | 2008-07-17 |
| NZ578262A (en) | 2012-02-24 |
| EP2118664A1 (de) | 2009-11-18 |
| US20100291612A1 (en) | 2010-11-18 |
| WO2008085024A1 (en) | 2008-07-17 |
| AU2008203970A1 (en) | 2008-07-17 |
| CA2674736A1 (en) | 2008-07-17 |
| US20100240088A1 (en) | 2010-09-23 |
| EP2118664B1 (de) | 2012-03-07 |
| AU2008203968A1 (en) | 2008-07-17 |
| WO2008085036A1 (en) | 2008-07-17 |
| EP2118662A1 (de) | 2009-11-18 |
| WO2008085035A1 (en) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2215257A4 (de) | Verfahren zur diagnose von tumorerkrankungen | |
| BR112013001752A2 (pt) | método de detectar doenças ou condições usando células fagocídicas | |
| UY32698A (es) | Marcadores de riesgo para enfermedades cardiovasculares | |
| EP2576839A4 (de) | Nukleinsäurenachweis und -quantifizierung durch posthybridisierungs-kennzeichnung und universelle kodierung | |
| DE602007011545D1 (de) | Automatisches System zur Durchführung von lokalisierten Bestandsaufnahmen | |
| DE602007001585D1 (de) | Verfahren zur herstellung von kunstlatex | |
| ATE522488T1 (de) | Verfahren zur herstellung von 1,2-dichlorethan | |
| ES2570334T3 (es) | Remodelado superficial de proteínas | |
| WO2014207049A3 (de) | Verfahren zur bestimmung von proteinaggregaten unter verwendung von oberflächen-fida | |
| EP2168728A4 (de) | Verfahren zur beurteilung von roboterfehlern | |
| EP2333107A4 (de) | Genexpressionsprofil als endometrialer rezeptivitätsmarker | |
| PH12015502849B1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
| BR112014021993A2 (pt) | detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto | |
| DK2140269T3 (da) | Proteinsignatur/markører til at detektere adenocarcinom | |
| BRPI0920989A2 (pt) | sistema de criação de plano de combinação e dotação de navio, método e programa para o mesmo | |
| EP2306225A4 (de) | Verfahren zur erkennung von direktleitungen | |
| ATE495286T1 (de) | Verfahren zur hydrolyse von polyphosphorsäure in polyareneazolfasern | |
| ES2414290R1 (es) | Metodo para el diagnostico y/o pronostico de dano renal agudo | |
| EP2650685A3 (de) | Verfahren und Kit zur Klassifizierung und Prognose von Wunden | |
| WO2011017656A3 (en) | Non-mass determined base compositions for nucleic acid detection | |
| WO2008049063A3 (en) | Method of identifying a device by gps coordinates | |
| AR059326A1 (es) | Resistencia a la mastitis | |
| EA200801533A1 (ru) | Производные антрахинона в качестве маркирующих веществ для жидкостей | |
| WO2013009143A3 (ko) | 당뇨망막병증 진단용 마커 및 이의 용도 | |
| DE602006002031D1 (de) | Legenest für geflügel |